Arkolith/Insider Trading/TVTX/Form 4

Dube Eric M

CHIEF EXECUTIVE OFFICER, DirectorTravere Therapeutics, Inc. (TVTX) · full profile →Form 4 · filed Apr 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.6M
Net Open-Market Flow
-$2.6M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Sell(S)57K$41.01$2.3M440K
Apr 15, 2026Sell(S)7K$41.75$299K433K
Apr 15, 2026Sell(S)20$42.66$853433K
Apr 13, 2026Grant(A)64K—$0497K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001763494-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML